p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins

Clinical Cancer Research

Volumn 13, Issue 20, 2007, Pages 6099-6106

  Huang, Xiaohong ^a   Pateromichelakis, Stelios ^a   Hills, Allison ^a   Sherriff, Martyn ^b   Lyons, Andrew ^a   Langdon, John ^a   Odell, Edward ^b   Morgan, Peter ^b   Harrison, John ^b   Partridge, Max ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; GENE MUTATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MUCOSA; PRIORITY JOURNAL; RECURRENCE RISK; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; MUTATION; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 35948940857     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1369     Document Type: Article

References (33)

1. Loree TR, Strong EW. Significance of positive margins in oral cavity squamous cell carcinoma. Am J Surg 1990;60:410-4.
2. Spiro RH, Guillamondegui O, Jr., Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 1999;21:408-13.
3. Johnson RE, Sigman JD, Funk GF. Quantification of surgical margin shrinkage in the oral cavity. Head Neck 1997;19:281-6.
4. Standards and datasets for reporting cancers. Datasets for histopathology reports on head and neck carcinomas and salivary neoplasms. 2nd ed. London: The Royal College of Pathologists; 2005.
5. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006;42:229-39.
6. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan ED. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 1999;35:257-65.
7. Weijers M, Snow GB, Bezemer PD, van der Wal JE, van der Waal I. The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of the mouth squamous cell carcinoma: an analysis of 37 patients. J Oral Pathol Med 2002;31:11-5.
8. Slootweg PJ, Hordijk GJ, Schade Y, Van Es RJJ, Koole R. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 2002;38:500-3.
9. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
10. Partridge M, Li S-R, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;60:2718-25.
11. Sardi I, Franchi A, Ferriero G, et al. Prediction of recurrence by microsatellite analysis in head and neck cancer. Genes Chromosomes Cancer 2000;29:201-6.
12. van Houten VM, van den Brekel MW, Kummer JA, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002;198:476-86.
13. van Hourten VMM, Leemans CR, Kummer JA, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res 2004;10:3614-20.
14. Temam S, Casiraghi O, Lahaye JB, et al. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma. Clin Cancer Res 2004;10:4022-8.
15. Partridge M, Gaballah K, Huang X. Molecular markers for diagnosis and prognosis. Cancer Metastasis Rev 2005;24:71-85.
16. Waridel F, Estreicher A, Bron L, et al. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 1997;14:163-9.
17. Raftery A. Bayesian model selection in social research. Sociol Methodol 1995;25:111-63.
18. Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461-4.
19. Pateromichelakis S, Farahini M, Phillips E, Partridge M. Molecular analysis of paired tumours: time to start treating the field. Oral Oncol 2005;41:916-26.
20. Evans SJW, Langdon JD, Rapidis, Johnson NW. Prognostic significance of STNMP and velocity of tumour growth in oral cancer. Cancer 1982;49:773-6.
21. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon JD. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral SCC within a field of cancerization. Cancer Res 2000;60:3893-8.
22. Braakhuis BJM, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198-206.
23. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Clin Cancer Res 1996;56:2484-7.
24. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from single preneoplastic lesions. Am J Pathol 2002;161:1051-60.
25. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333-7.
26. Kashiwazaki H, Tonoki H, Tada M, et al. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene1997;15:2667-74.
27. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A 1987;84:2302-6.
28. Harden SV, Thomas DC, Benoit N, et al. Real-time Gap ligase chain reaction: a rapid semiquantitative assay for detecting p53 mutation at low levels in surgical margins and lymph nodes from resected lung and head and neck tumors. Clin Cancer Res 2004;10:2379-85.
29. Shi C, Eshelman SH, Jones D, et al. LigAmp for sensitive detection of single-nucleotide differences. Nat Methods 2004;2:1-7.
30. Woolgar JA, Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol 2005;41:1034-43.
31. Braakhuis BJM, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005;15:113-20.
32. Partridge M, Brakenhoff RH, Phillips E, et al. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 2003;9:5287-94.
33. Giaccone G. Clinical impact of novel treatment strategies. Oncogene 2002;21:6970-81.